These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 21343343)

  • 21. [Akathisia in the course of olanzapine treatment].
    Makkos Z; Csonka A
    Neuropsychopharmacol Hung; 2006 Dec; 8(4):215-7. PubMed ID: 17211056
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Four cases of venous thromboembolism associated with olanzapine.
    Maly R; Masopust J; Hosak L; Urban A
    Psychiatry Clin Neurosci; 2009 Feb; 63(1):116-8. PubMed ID: 19067990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Olanzapine-induced tardive dystonia successfully treated by tetrabenazine.
    Rauchverger B; Isakov V; Jabarin M
    J Neuropsychiatry Clin Neurosci; 2007; 19(4):484-5. PubMed ID: 18070868
    [No Abstract]   [Full Text] [Related]  

  • 24. Eosinophilia Associated With Olanzapine.
    Tournikioti K; Douzenis A; Antoniadou A; Papazahos K; Moschos C; Papageorgiou C; Rizos EN
    J Clin Psychopharmacol; 2016 Apr; 36(2):180-1. PubMed ID: 26872116
    [No Abstract]   [Full Text] [Related]  

  • 25. Olanzapine postinjection delirium/sedation syndrome: an unrecognized diagnosis in the emergency department.
    Vodovar D; Malissin I; Deye N; Baud FJ; Mégarbane B
    J Emerg Med; 2014 Jul; 47(1):e23-4. PubMed ID: 24199723
    [No Abstract]   [Full Text] [Related]  

  • 26. Possible olanzapine-induced hepatotoxicity in a young Chinese patient.
    Lui SY; Tso S; Lam M; Cheung EF
    Hong Kong Med J; 2009 Oct; 15(5):394-6. PubMed ID: 19801701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Olanzapine-induced eccrine squamous syringometaplasia.
    Molina-Ruiz AM; Molina-Ruiz RM; Zulueta T; Barabash R; Requena L
    Am J Dermatopathol; 2012 Jun; 34(4):434-7. PubMed ID: 22257902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Olanzapine-induced acute pancreatitis.
    Baysal B; Kayar Y; Özmen A; ElShobaky M; Mahdi N; İnce AT; Danalıoğlu A; Şentürk H
    Turk J Gastroenterol; 2015 May; 26(3):289-90. PubMed ID: 26006214
    [No Abstract]   [Full Text] [Related]  

  • 29. Safety of olanzapine use in adolescents.
    Schulz C; Haight RJ
    Expert Opin Drug Saf; 2013 Sep; 12(5):777-82. PubMed ID: 23876012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of aripiprazole on prolactin levels in subjects with schizophrenia during cross-titration with risperidone or olanzapine: analysis of a randomized, open-label study.
    Byerly MJ; Marcus RN; Tran QV; Eudicone JM; Whitehead R; Baker RA
    Schizophr Res; 2009 Feb; 107(2-3):218-22. PubMed ID: 19038534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Olanzapine: a 5-year perspective.
    Littrell KH; Petty RG; Wolf NM
    Expert Rev Neurother; 2006 Jun; 6(6):811-21. PubMed ID: 16784405
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical consequences of switching antipsychotic drugs in outpatients with schizophrenia: 36-month results from the European Schizophrenia Outpatient Health Outcomes study.
    Novick D; Haro JM; Suarez D; Marques-Teixeira J; Naber D
    Int Clin Psychopharmacol; 2008 Jul; 23(4):203-8. PubMed ID: 18545058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Post-injection delirium/sedation syndrome following injection of olanzapine pamoate: a new syndrome in emergency psychiatry].
    Buts K; Van Hecke J
    Tijdschr Psychiatr; 2014; 56(4):273-6. PubMed ID: 24807388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparing tolerability of olanzapine in schizophrenia and affective disorders: a meta-analysis.
    Baldessarini RJ
    Drug Saf; 2012 Dec; 35(12):1183; author reply 1183-4. PubMed ID: 23137152
    [No Abstract]   [Full Text] [Related]  

  • 35. Olanzapine pamoate - blockbuster or damp squib?
    Taylor DM
    Int J Clin Pract; 2009 Apr; 63(4):540-1. PubMed ID: 19335703
    [No Abstract]   [Full Text] [Related]  

  • 36. Olanzapine long-acting injection: a 24-week, randomized, double-blind trial of maintenance treatment in patients with schizophrenia.
    Kane JM; Detke HC; Naber D; Sethuraman G; Lin DY; Bergstrom RF; McDonnell D
    Am J Psychiatry; 2010 Feb; 167(2):181-9. PubMed ID: 20008947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Tardive dyskinesia in patients with schizophrenia treated with olanzapine - results from a 20-month, prospective, open study under naturalistic conditions].
    Szafrański T
    Psychiatr Pol; 2014; 48(6):1155-65. PubMed ID: 25717485
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Olanzapine treatment of eight adolescent patients with psychosis.
    Ercan ES; Kutlu A; Varan A; Cikoğlu S; Coşkunol H; Bayraktar E
    Hum Psychopharmacol; 2004 Jan; 19(1):53-6. PubMed ID: 14716713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypothermia following antipsychotic drug use.
    van Marum RJ; Wegewijs MA; Loonen AJ; Beers E
    Eur J Clin Pharmacol; 2007 Jun; 63(6):627-31. PubMed ID: 17401555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blonanserin improved dystonia induced by risperidone or olanzapine in two patients with schizophrenia.
    Takaki M; Mizuki Y; Miki T
    J Neuropsychiatry Clin Neurosci; 2014 Apr; 26(2):E14. PubMed ID: 24763772
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.